Lungevity Foundation is a 501(c)(3) organization, classified under Medical Research (NTEE H124). Contributions are tax-deductible.
332 S Michigan Ave Ste 900, Chicago, IL 60604-4393
Among the 25 scored medical research organizations in Chicago, Lungevity Foundation holds 4.3 months of operating reserves (peer median 16.9 months), runs a typical yearly deficit of 13.5% (peers: surplus of 0.3%), and has cut spending 11.1% a year (peers: grown spending 6.1% a year).
In fiscal year 2025 it reported $14,237,969 in revenue and $14,555,858 in expenses, with contributions making up 102.7% of revenue.
Lungevity's vision is a world where no one dies of lung cancer. Lungevity Foundation is firmly committed to making an immediate impact on increasing quality-of-life and survivorship of people with lung cancer by accelerating research into early detection and more effective treatments, as well as providing community, support and education for all those affected by the disease. By keeping patients at the center of all we do, we are transforming lung cancer and making progress every single day.lungevity moves forward firmly resolved to provide the energy, inspiration, and resources that are critical to making lung cancer a national priority. Lungevity is a responsible steward of your donation, spending it to transform lung cancer.
Largest programs · fiscal year 2025
Research services - funding clinical research awards in lung cancer to bring advances in clinical research more rapidly to patient care.$5,359,739 spent · 43.3% of program spending
Patient and public education - creates, updates and maintains a collection of educational tools and materials for patients, caregivers, and healthcare professionals.$3,474,079 spent · 28.0% of program spending
Improving access to care - works to improve access to life-saving care in underserved communities through various initiatives, including efforts to streamline the clinical trial process and make it more accessible to patients, and ensuring biomarker testing is available to all patients diagnosed with non-small cell lung cancer.$2,168,425 spent · 17.5% of program spending
Support services - offers the largest online network of support and in-person survivorship programs for all people affected by lung cancer, including message boards, peer-to-peer support matching service, and national survivor summits.$1,383,182 spent · 11.2% of program spending
Where each dollar went · fiscal year 2025
Of every dollar it spent, 85¢ went to programs, 5¢ to management and 10¢ to fundraising.
Programs $12,385,425
Management $690,870
Fundraising $1,479,563
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Spending on programs Not scored; America's Best needs 65%+
85%
Meets
Compared with Chicago peers
Measure
This organization
Peer median
Operating reserves
4.3 mo
16.9 mo
Typical margin
−13.5%
+0.3%
Spending growth
−11.1% / yr
+6.1% / yr
Debt load
15.5%
11.3%
Peers: the 25 Chicago medical research organizations with a score, ranked or below the bar.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$14,237,969Fiscal year 2025
Expenses$14,555,858Fiscal year 2025
Total assets$6,169,133Fiscal year 2025
Total liabilities$956,735Fiscal year 2025
Fiscal year ending June2025
Revenue$14,237,969
Expenses$14,555,858
Net income−$317,889
Net assets$5,212,398
Notable sources of revenue
Percent of total revenue
Contributions
$14,627,477
102.7%
Program services
$0
0.0%
Investment income
$36,657
0.3%
Other (net)
−$426,165
−3.0%
Assets / debt
Total assets
$6,169,133
Total liabilities
$956,735
Net assets
$5,212,398
Compensation
Not in our extract for this year.
Fiscal year ending June2024
Revenue$13,750,114
Expenses$15,901,116
Net income−$2,151,002
Net assets$5,530,287
Notable sources of revenue
Percent of total revenue
Contributions
$14,212,142
103.4%
Program services
$0
0.0%
Investment income
−$93
−0.0%
Other (net)
−$461,935
−3.4%
Assets / debt
Total assets
$6,220,479
Total liabilities
$690,192
Net assets
$5,530,287
Compensation
Not in our extract for this year.
Fiscal year ending June2023
Revenue$14,391,489
Expenses$18,403,410
Net income−$4,011,921
Net assets$7,681,289
Notable sources of revenue
Percent of total revenue
Contributions
$14,661,126
101.9%
Program services
$0
0.0%
Investment income
$2,116
0.0%
Other (net)
−$271,753
−1.9%
Assets / debt
Total assets
$8,760,023
Total liabilities
$1,078,734
Net assets
$7,681,289
Compensation
Officers and key employees
$1,047,557
Share of expenses
5.7%
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?